Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Other Non-Current Liabilities (2016 - 2017)

Tenax Therapeutics' Other Non-Current Liabilities history spans 6 years, with the latest figure at $36078.0 for Q3 2017.

  • For Q3 2017, Other Non-Current Liabilities fell 88.37% year-over-year to $36078.0; the TTM value through Sep 2017 reached $36078.0, down 88.37%, while the annual FY2016 figure was $226092.0, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q3 2017 was $36078.0 at Tenax Therapeutics, down from $72157.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.1 million in Q1 2014 and bottomed at -$33900.0 in Q2 2014.
  • The 5-year median for Other Non-Current Liabilities is $370405.0 (2016), against an average of $391829.0.
  • The largest annual shift saw Other Non-Current Liabilities soared 1788.63% in 2015 before it tumbled 88.37% in 2017.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $65592.0 in 2013, then skyrocketed by 992.75% to $716759.0 in 2014, then decreased by 26.85% to $524340.0 in 2015, then plummeted by 56.88% to $226092.0 in 2016, then plummeted by 84.04% to $36078.0 in 2017.
  • Per Business Quant, the three most recent readings for TENX's Other Non-Current Liabilities are $36078.0 (Q3 2017), $72157.0 (Q2 2017), and $55320.0 (Q1 2017).